Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+135.3%
5Y CAGR+114.4%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+135.3%/yr
vs +25.6%/yr prior
5Y CAGR
+114.4%/yr
Recent acceleration
Acceleration
+109.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
45.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $51.63M | +27.7% |
| 2024 | $40.45M | +400.6% |
| 2023 | $8.08M | +103.8% |
| 2022 | $3.96M | +6398.4% |
| 2021 | $61000.00 | -94.7% |
| 2020 | $1.14M | -66.5% |
| 2019 | $3.41M | +113.8% |
| 2018 | $1.59M | +5416.7% |
| 2017 | $-30000.00 | -220.0% |
| 2016 | $25000.00 | - |